ARCH-backed start­up Met­sera launch­es with $290M to take on obe­si­ty gi­ants

A new start­up aims to chal­lenge No­vo Nordisk and Eli Lil­ly’s du­op­oly atop to­day’s mar­ket for obe­si­ty drugs.

The start­up Met­sera of­fi­cial­ly launched Thurs­day, an­nounc­ing …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER